Blueberrypharmaceuticals

Hertab 250mg tablets are categorized as anti-neoplastic agent, which is orally active drug used for treating breast cancer. Hertab tablets are comes under biological category which is targeted chemotherapy. Hertab tablets are classified as; 1. Tyrosine kinase prohibitor 2. Stop the HER2/neu & epidermal growth factor receptor activity 3. Targeted therapy 4. Signal transduction prohibitor PRODUCT DETAILS Brand               Hertab Ingredients        Lapatinib Strength           250mg Manufactured   Hetero DOSAGE In HER2 positive advanced breast cancer: The recommended dose of Hertab is 1250mg should be administered orally as a single dose on day 1 to 21repeatedly combined with Capecitabine 2000mg/m2/day (should be taken orally in 2 doses relatively 12 hours apart) on day 1 to 14 in continuous 21 day cycle. Totally 5 tablets of Hertab should be taken at a time as whole. In hormone receptor positive HER 2 positive advance breast cance

Tykerb 250mg tablets are categorized as anti-neoplastic agent, which is orally active drug used for treating breast cancer. Tykerb tablets are comes under biological category which is targeted chemotherapy. Tykerb tablets are classified as; 1. Tyrosine kinase prohibitor 2. Stop the HER2/neu & epidermal growth factor receptor activity 3. Targeted therapy 4. Signal transduction prohibitor PRODUCT DETAILS Brand                    Tykerb Ingredients            Lapatinib Strength                250mg Manufactured       GSK DOSAGE In HER2 positive advanced breast cancer: The recommended dose of Tykerb is 1250mg should be administered orally as a single dose on day 1 to 21repeatedly combined with Capecitabine 2000mg/m2/day (should be taken orally in 2 doses relatively 12 hours apart) on day 1 to 14 in continuous 21 day cycle. Totally 5 tablets of Tykerb should be taken at a time as whole. In hormone receptor positive HER 2 positive advance breast cance